Get startedLog in
    Picture of POINT Biopharma Global logo

    PNT — POINT Biopharma Global News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid Cap
    All News

    Brief: Point Biopharma Provides Early-Stage Program Updates

    Picture of POINT Biopharma Global logoPOINT Biopharma Global
    14/02/2022 13:42
    Feb 14 (Reuters) - POINT Biopharma Global Inc  PNT.O :
    * POINT BIOPHARMA PROVIDES EARLY-STAGE PROGRAM UPDATES
    * POINT BIOPHARMA GLOBAL- PHASE 1 THERAPEUTIC TRIAL FOR
PNT6555,
PLANNED FOR SUMMER 2022
    * POINT BIOPHARMA GLOBAL INC - FOR PNT2001, IND-ENABLING
STUDIES
WITH ACTINIUM-225 PLANNED FOR 2022, IND/CTA FILING EXPECTED H1
2023

Source text for Eikon:  ID:nGNX4tDyJS 
Further company coverage:  PNT.O 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on POINT Biopharma Global

    See all news